| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2001 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2005 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2016 | ||||||||
|
EWS RNA binding protein 1 | 0.474 | 0.692 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2018 | ||||||||
|
transcription factor binding to IGHM enhancer 3 | 0.542 | 0.654 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
fibroblast growth factor 23 | 0.460 | 0.731 | 3.1E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2018 | ||||||||
|
NGFI-A binding protein 2 | 0.641 | 0.577 | 0.57 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2016 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
nuclear receptor subfamily 4 group A member 3 | 0.502 | 0.808 | 0.91 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2013 | ||||||||
|
lipocalin 2 | 0.405 | 0.885 | 1.1E-09 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2005 | 2006 | ||||||||
|
microRNA 200c | 0.486 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | |||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
protein phosphatase 6 regulatory subunit 3 | 0.716 | 0.385 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
high mobility group AT-hook 2 | 0.429 | 0.808 | 0.87 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ubiquitin conjugating enzyme E2 D1 | 0.700 | 0.385 | 0.12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
cathepsin L | 0.488 | 0.846 | 8.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |